You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

List of Excipients in API voriconazole


✉ Email this page to a colleague

« Back to Dashboard


Excipients in NDA-approved (novel) drugs containing voriconazole

Glossary
Company Tradename Ingredient NDC Excipient Potential Generic Entry
Roerig VFEND voriconazole 0049-3170 CROSCARMELLOSE SODIUM
Roerig VFEND voriconazole 0049-3170 HYPROMELLOSE
Roerig VFEND voriconazole 0049-3170 LACTOSE MONOHYDRATE
Roerig VFEND voriconazole 0049-3170 MAGNESIUM STEARATE
Roerig VFEND voriconazole 0049-3170 POVIDONE
Roerig VFEND voriconazole 0049-3170 TITANIUM DIOXIDE
>Company >Tradename >Ingredient >NDC >Excipient >Potential Generic Entry

Subscribe to access the full database, or Subscribe

Excipients in ANDA-approved (generic) drugs containing voriconazole

Company Ingredient NDC Excipient
Mylan Pharmaceuticals Inc voriconazole 0378-1626 CROSCARMELLOSE SODIUM
Mylan Pharmaceuticals Inc voriconazole 0378-1626 HYPROMELLOSE 2910
Mylan Pharmaceuticals Inc voriconazole 0378-1626 LACTOSE MONOHYDRATE
Mylan Pharmaceuticals Inc voriconazole 0378-1626 MAGNESIUM STEARATE
Mylan Pharmaceuticals Inc voriconazole 0378-1626 POVIDONE
Mylan Pharmaceuticals Inc voriconazole 0378-1626 STARCH, CORN
>Company >Ingredient >NDC >Excipient

Subscribe to access the full database, or Subscribe

Detailed excipient profiles for voriconazole

Excipient focus: ANHYDROUS CITRIC ACID

Excipient focus: BETADEX SULFOBUTYL ETHER SODIUM

Excipient focus: CROSCARMELLOSE SODIUM

Excipient focus: HYDROXYPROPYL BETADEX

Excipient focus: HYDROXYPROPYLBETADEX

Excipient focus: HYPROMELLOSE

Excipient focus: HYPROMELLOSE 2910

Excipient focus: LACTOSE MONOHYDRATE

Excipient focus: MAGNESIUM STEARATE

Excipient focus: POLYETHYLENE GLYCOL

Excipient focus: POLYETHYLENE GLYCOL 6000

Excipient focus: POLYVINYL ALCOHOL

Excipient focus: POVIDONE

Excipient focus: POVIDONE K30

Excipient focus: SILICON DIOXIDE

Excipient focus: SODIUM BENZOATE

Excipient focus: SODIUM CITRATE

Excipient focus: STARCH, CORN

Excipient focus: STARCH, PREGELATINIZED CORN

Excipient focus: SUCROSE

Excipient focus: SULFOBUTYLETHER .BETA.-CYCLODEXTRIN

Excipient focus: TALC

Excipient focus: TITANIUM DIOXIDE

Excipient focus: TRIACETIN

Excipient focus: TRISODIUM CITRATE DIHYDRATE

Excipient focus: XANTHAN GUM

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

 
© Copyright 2002-2024 thinkBiotech LLC
ISSN: 2162-2639
Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
 NCE-1 Patent Challenge Dates 2024 - 2025
 Trigger-based marketing for the life sciences
 Get DrugPatentWatch Business Intelligence Reports at Amazon.com
 DrugChatter - AI-based answers to questions about drugs
 RxJam - Digital Marketing for Life Sciences
Preferred Citation:

Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
   See Primary Research Papers Citing DrugPatentWatch

Links

Follow DrugPatentWatch:

  DrugPatentWatch Linkedin Group